secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001104659-25-051136
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Elanco annual meeting results: directors elected, say-on-pay approved with 46.5% dissent
--------------------------------------------------------------------------------

- Directors Kapila K. Anand and Paul Herendeen elected; Anand faced 156M votes against (34%).
- Non-binding say-on-pay approved 244.5M to 212.5M (46.5% opposed).
- Ratification of Ernst & Young as auditor passed with 470.1M votes in favor.
- Advisory vote on executive compensation will be held annually until 2031.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925051136/0001104659-25-051136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925051136/tm2515582d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-051136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer